Astrimmune

For high throughput fluid-flow cell imaging for bladder cancer monitoring and diagnosis, Astrimmune has developed the unique capability to biochemically analyse and image individual cells en masse under high-speed flow conditions. The company will develop enabling software tools to allow application of the technique as a cheaper, non-invasive alternative to cystoscopy for the post-surgical monitoring of bladder cancer.